Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Diabetes
•
Endocrinology
Do patients with advanced chronic kidney disease tend to have falsely high HbA1c or falsely low HbA1c levels?
https://doi.org/10.2337/dc22-1399
Related Questions
When managing patients with suspected MASLD, what specific criteria or findings would prompt you to refer them to hepatology?
When should metformin be stopped before surgery and when is it considered safe to resume?
Is it safe to prescribe Invokana or Metformin for patients taking Biktarvy?
Is ABI (Ankle Brachial index) lower limb arterial doppler not recommended if patient already has arterial stents in the legs, and if so, what other imaging modality would you consider as first-line?
How do you adjust your HbA1c goal for managing diabetes in elderly patients with multiple chronic illnesses but no limitations in performing self-care tasks?
How do you adjust your management strategy to address the unique needs of anuric end-stage kidney disease patients when treating diabetic ketoacidosis?
How do you approach the use of metformin in the management of prediabetes for patients who are neither obese nor have a family history of diabetes?
Would you recommend statin initiation in a young adult patient (age < 40) with type 1 diabetes mellitus and LDL cholesterol levels greater than 100 without any cardiovascular risk factors?
How do you counsel patients on the use of compounded weight loss medications?
What patient specific factors outside of health insurance coverage do you use to decide which GLP1 R agonist or dual agonist therapy to start in patients with diabetes?
